International Assets Investment Management LLC Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

International Assets Investment Management LLC grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1,513.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,066 shares of the company’s stock after purchasing an additional 2,876 shares during the quarter. International Assets Investment Management LLC’s holdings in Option Care Health were worth $103,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in OPCH. Vanguard Group Inc. grew its position in Option Care Health by 11.8% during the third quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company’s stock valued at $624,981,000 after buying an additional 2,037,162 shares during the period. Third Point LLC grew its position in shares of Option Care Health by 55.7% during the 3rd quarter. Third Point LLC now owns 5,450,659 shares of the company’s stock valued at $176,329,000 after acquiring an additional 1,950,659 shares during the period. Assenagon Asset Management S.A. acquired a new stake in shares of Option Care Health during the 3rd quarter valued at about $36,239,000. Fiera Capital Corp purchased a new position in shares of Option Care Health in the 3rd quarter valued at about $21,370,000. Finally, Riverbridge Partners LLC raised its holdings in Option Care Health by 49.5% in the 4th quarter. Riverbridge Partners LLC now owns 1,792,012 shares of the company’s stock worth $60,373,000 after purchasing an additional 593,706 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Jefferies Financial Group raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 24th.

Option Care Health Stock Up 2.2 %

OPCH opened at $30.25 on Tuesday. The company has a market cap of $5.26 billion, a PE ratio of 19.90, a price-to-earnings-growth ratio of 1.45 and a beta of 1.22. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The company has a 50-day moving average price of $31.88 and a 200 day moving average price of $31.47. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04. The company had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. Option Care Health’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.21 EPS. Sell-side analysts expect that Option Care Health, Inc. will post 1.18 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The shares were bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.